Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related CYCC
The Week Ahead: Earnings, Earnings, And More Earnings
12 Biggest Mid-Day Losers For Friday
Cyclacel optimistic with subgroup of patients in failed late-stage study of sapacitabine; investors not on board, shares down 7% (Seeking Alpha)
Related OPK
Lightning Round: Jim Cramer Gives His Opinion On Lowe's Companies, Blackstone And More
51 Biggest Movers From Yesterday

Analysts at SunTrust Robinson Humphrey initiated initiated coverage on Dynegy Inc. (NYSE: DYN) with a Neutral rating. The target price for Dynegy is set to $25. Dynegy shares closed at $23.62 on Thursday.

H.C. Wainwright initiated coverage on Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) with a Buy rating. Cyclacel Pharmaceuticals shares closed at $0.550 on Thursday.

SunTrust Robinson Humphrey initiated coverage on NRG Energy Inc (NYSE: NRG) with a Neutral rating. The target price for NRG Energy is set to $16. NRG Energy shares closed at $15.38 on Thursday.

Analysts at JPMorgan initiated coverage on Opko Health Inc. (NYSE: OPK) with a Overweight rating. The target price for Opko Health is set to $14. Opko Health shares closed at $9.28 on Thursday.

Analysts at SunTrust Robinson Humphrey initiated coverage of Talen Energy Corp (NYSE: TLN) with a Buy rating. The target price for Talen Energy is set to $14. Talen Energy shares closed at $10.17 on Thursday.

Latest Ratings for CYCC

DateFirmActionFromTo
Oct 2015H.C. WainwrightInitiates Coverage onBuy
Dec 2014JMP SecuritiesDowngradesMarket OutperformMarket Perform
Jul 2013JMP SecuritiesInitiates Coverage onMarket Outperform

View More Analyst Ratings for CYCC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (CYCC + DYN)

View Comments and Join the Discussion!

Partner Center